Related Experiment Videos

[Different combination of drugs regarding the damage on organs targeting salt sensitivity or non-salt-sensitive

Qi Wu1, Xiao-juan Qin, Yan-tian Tang

  • 1Department of Internal Medicine-Cardiovascular, Beilun District People's Hospital of Ningbo, Ningbo 315800, China.

Abstract

Insights

For salt-sensitive hypertension, perindopril with indapamide improved organ damage markers. For non-salt-sensitive hypertension, perindopril with felodipine was more suitable, showing distinct treatment efficacies for different hypertension types.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Endocrinology

Context:

  • Hypertension management requires tailored therapeutic strategies.
  • Salt sensitivity influences organ damage in hypertensive patients.
  • Optimizing drug combinations is crucial for effective hypertension treatment.

Purpose:

  • To investigate organ damage in salt-sensitive (SS) versus non-salt-sensitive (NSS) hypertension.
  • To evaluate the efficacy of two drug combinations: felodipine/perindopril and indapamide/perindopril.
  • To determine the optimal drug selection based on salt sensitivity in hypertensive patients.

Summary:

  • 120 hypertensive patients (60 SS, 60 NSS) were treated for 12 weeks with either felodipine/perindopril or indapamide/perindopril.
  • Treatment effects on blood pressure, insulin resistance, and organ damage markers (e.g., left ventricular mass index, urinary albumin) were assessed.
  • Indapamide/perindopril showed significant improvements in SS patients, while felodipine/perindopril was more effective in NSS patients.

Impact:

  • Provides evidence for personalized hypertension treatment based on salt sensitivity.
  • Highlights differential efficacy of drug combinations in managing target organ damage.
  • Informs clinical decision-making for selecting antihypertensive therapies in diverse hypertensive populations.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...